Answer
Adequate data on FEIBA during breastfeeding are lacking; its large coagulation-factor proteins are likely present in breast milk in very low amounts, but physicians should balance potential risks and prescribe only if clearly needed, considering the increased postpartum risk of thromboembolic events.
Sources for this answer
- FEIBA 100 U/ml powder and solvent for solution for infusionTakeda UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 2Document updated
Sources checked